High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype–Phenotype Correlation

Kitiwan Rojnueangnit(University of Alabama at Birmingham), Jing Xie(University of Alabama at Birmingham), Alicia Gomes(University of Alabama at Birmingham), Angela Sharp(University of Alabama at Birmingham), Tom Callens(University of Alabama at Birmingham), Yunjia Chen(University of Alabama at Birmingham), Ying Liu(University of Alabama at Birmingham), J. Nicholas Cochran(University of Alabama at Birmingham), Mary‐Alice Abbott(Tufts University), Joan Atkin(Nationwide Children's Hospital), Dusica Babovic‐Vuksanovic(Mayo Clinic), Christopher Barnett(The University of Adelaide), Melissa Crenshaw(Johns Hopkins University), Dennis W. Bartholomew(Nationwide Children's Hospital), Lina Basel(Rabin Medical Center), Gary A. Bellus(University of Colorado Denver), Shay Ben‐Shachar(Tel Aviv Sourasky Medical Center), Martin G. Bialer(Northwell Health), David Bick(Medical College of Wisconsin), Bruce Blumberg(Kaiser Permanente Oakland Medical Center), Fanny Cortés(Clínica Las Condes), Karen L. David(NewYork–Presbyterian Brooklyn Methodist Hospital), Anne Destrèe(Institute of Pathology and Genetics), Anna Duat Rodríguez(Hospital Infantil Universitario Niño Jesús), Dawn Earl(Seattle Children's Hospital), Luis Escobar(Saint Vincent Health System), Marthanda Eswara(Sutter Medical Center), Begoña Ezquieta(Hospital General Universitario Gregorio Marañón), Ian M. Frayling(University Hospital of Wales), Moshe Frydman(Sheba Medical Center), Kathy Gardner(University of Pittsburgh), Karen W. Gripp(Community Health Systems - Dupont Hospital), Concepción Hernández‐Chico(Instituto Ramón y Cajal de Investigación Sanitaria), Kurt Heyrman(Health Center), Jennifer Ibrahim(St. Joseph’s Children’s Hospital), Sandra Janssens(Ghent University Hospital), Beth Keena(University of Pennsylvania), Isabel Llano‐Rivas(BioCruces Health research Institute), Kathy Leppig(University of Washington), Marie McDonald(Duke Medical Center), Vinod K. Misra(Wayne State University), Jennifer Mulbury(University of Rochester Medical Center), Vinodh Narayanan(Translational Genomics Research Institute), Naama Orenstein(Schneider Children's Medical Center), Patricia Galvin‐Parton(Stony Brook Medicine), Hélio Pedro(Hackensack University Medical Center), Enikö K. Pivnick(Le Bonheur Children's Hospital), Cynthia M. Powell(University of North Carolina at Chapel Hill), Linda M. Randolph(Children's Hospital of Los Angeles), Salmo Raskin(Pontifícia Universidade Católica do Paraná), Jordi Rosell(Hospital Universitario Son Espases), Karol Rubin(University of Minnesota Children's Hospital), Margretta R. Seashore(Pediatrics and Genetics), Christian P. Schaaf(Baylor College of Medicine), Angela E. Scheuerle(The University of Texas Southwestern Medical Center), Meredith Schultz(Nationwide Children's Hospital), Elizabeth K. Schorry(University of Cincinnati), Rhonda E. Schnur(Cooper Medical School of Rowan University), Elizabeth Siqveland(Children's Minnesota), Amanda Tkachuk(University of Colorado Denver), James H. Tonsgard(University of Chicago), Meena Upadhyaya(University Hospital of Wales), Ishwar C. Verma(Sir Ganga Ram Hospital), Stephanie E Wallace(University of Washington), Charles A. Williams(University of Florida), Elaine H. Zackai(Children's Hospital of Philadelphia), Jonathan Zonana(Oregon Health & Science University), Conxi Lázaro(Institut Català d'Oncologia), Kathleen Claes(Ghent University Hospital), Bruce R. Korf(University of Alabama at Birmingham), Yolanda Martín(Instituto Cajal), Eric Legius(KU Leuven), Ludwine Messiaen(University of Alabama at Birmingham)
Human Mutation
July 14, 2015
Cited by 190Open Access
Full Text

Abstract

Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worldwide. Identification of genotype-phenotype correlations is challenging because of the wide range clinical variability, the progressive nature of the disorder, and extreme diversity of the mutational spectrum. We report 136 individuals with a distinct phenotype carrying one of five different NF1 missense mutations affecting p.Arg1809. Patients presented with multiple café-au-lait macules (CALM) with or without freckling and Lisch nodules, but no externally visible plexiform neurofibromas or clear cutaneous neurofibromas were found. About 25% of the individuals had Noonan-like features. Pulmonic stenosis and short stature were significantly more prevalent compared with classic cohorts (P < 0.0001). Developmental delays and/or learning disabilities were reported in over 50% of patients. Melanocytes cultured from a CALM in a segmental NF1-patient showed two different somatic NF1 mutations, p.Arg1809Cys and a multi-exon deletion, providing genetic evidence that p.Arg1809Cys is a loss-of-function mutation in the melanocytes and causes a pigmentary phenotype. Constitutional missense mutations at p.Arg1809 affect 1.23% of unrelated NF1 probands in the UAB cohort, therefore this specific NF1 genotype-phenotype correlation will affect counseling and management of a significant number of patients.


Related Papers

No related papers found

Powered by citation graph analysis